comparemela.com

Latest Breaking News On - Obseva sa - Page 4 : comparemela.com

Recent Research Analysts Ratings Changes for ObsEva (OBSV)

ObsEva (NASDAQ: OBSV) has recently received a number of price target changes and ratings updates: 6/5/2022 – ObsEva was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 6/3/2022 – ObsEva is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $6.00 price target on the […]

Morgan stanleyGeode capital managementCantor fitzgeraldGoldman sachs group incZacks investment researchCanaccord genuity group incCapital partnersGet ratingSachs groupCapital managementObseva saNasdaq obsv

ObsEva Announces Corporate Updates

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Shauna dillonManagement incExchange commissionExchange commission onSwiss exchangeAmendment agreementSecurities purchase agreementSecurities purchaseNasdaq global select marketNote regarding forward looking statementsPrivate securities litigation reform actRisk factorsAnnual reportGlobe newswireObseva sa

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Announces Corporate Updates

Investegate announcements from ObsEva SA, ObsEva Announces Corporate Updates

Shauna dillonManagement incExchange commissionExchange commission onSwiss exchangeObseva announces corporateAmendment agreementSecurities purchase agreementSecurities purchaseNasdaq global select marketNote regarding forward looking statementsPrivate securities litigation reform actRisk factorsAnnual reportInvestegate announcementsInvestegate company announcements

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

Investegate announcements from ObsEva SA, ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

United statesKarolinska institutetShauna dillonJacques donnezBrandi howardHugh taylorKristina gemzell danielssonProgram in uterine fibroidsInternational society of gynecological endocrinologyYale school of medicineSociety of endometriosisDrug administrationInternational societyEuropean commissionSwiss exchangeExchange commission

ObsEva Presents Clinical Data on Oral GnRH Antagonist

-Data featured in two oral presentations at the 8th Society of Endometriosis and Uterine Disorders Congress and a poster presentation at the International.

United statesKarolinska institutetJacques donnezBrandi howardHugh taylorKristina gemzell danielssonYale school of medicineProgram in uterine fibroidsSociety of endometriosisInternational society of gynecological endocrinologyInternational societySwiss exchangeUterine disorders congressCatholic university of louvainKisseipharmaceutical co ltdWorld congress

vimarsana © 2020. All Rights Reserved.